Drug-Target Association Kinetics in Drug Discovery

被引:53
作者
IJzerman, Adriaan P. [1 ]
Guo, Dong [2 ]
机构
[1] Leiden Univ, LACDR, Div Drug Discovery & Safety, POB 9502, NL-2300 RA Leiden, Netherlands
[2] Xuzhou Med Univ, Jiangsu Key Lab New Drug Res & Clin Pharm, 209 Tongshan Rd, Xuzhou 221004, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
PROTEIN-COUPLED RECEPTOR; BINDING-KINETICS; RESIDENCE TIME; IN-VIVO; LIGAND-BINDING; LONG; DISSOCIATION; MECHANISM; EFFICACY; PHARMACOLOGY;
D O I
10.1016/j.tibs.2019.04.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The important role of ligand-receptor binding kinetics in drug design and discovery is increasingly recognized by the drug research community. Over the past decade, accumulating evidence has shown that optimizing the ligand's dissociation rate constant can lead to desirable duration of in vivo target occupancy and, hence, improved pharmacodynamic properties. However, the association rate constant as a pharmacological principle remains less investigated, whereas it can play an equally important role in the selection of drug candidates. This review provides a compilation and discussion of otherwise scarce and dispersed information on this topic, bringing to light the importance of drug -target association in kinetics-directed drug design and discovery.
引用
收藏
页码:861 / 871
页数:11
相关论文
共 88 条
[81]   Compound Selectivity and Target Residence Time of Kinase Inhibitors Studied with Surface Plasmon Resonance [J].
Willemsen-Seegers, Nicole ;
Uitdehaag, Joost C. M. ;
Prinsen, Martine B. W. ;
de Vetter, Judith R. F. ;
de Man, Jos ;
Sawa, Masaaki ;
Kawase, Yusuke ;
Buijsman, Rogier C. ;
Zaman, Guido J. R. .
JOURNAL OF MOLECULAR BIOLOGY, 2017, 429 (04) :574-586
[82]   Binding pathway of histamine to the hH4R, observed by unconstrained molecular dynamics [J].
Wittmann, Hans-Joachim ;
Strasser, Andrea .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (06) :1259-1268
[83]   Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor [J].
Wong, Pancras C. ;
Pinto, Donald J. P. ;
Zhang, Donglu .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (04) :478-492
[84]   A binding kinetics study of human adenosine A3 receptor agonists [J].
Xia, Lizi ;
Kyrizaki, Athina ;
Tosh, Dilip K. ;
van Duijl, Tirsa T. ;
Roorda, Jacomina Cornelia ;
Jacobson, Kenneth A. ;
Ijzerman, Adriaan P. ;
Heitman, Laura H. .
BIOCHEMICAL PHARMACOLOGY, 2018, 153 :248-259
[85]   A two-step binding mechanism for the self-binding peptide recognition of target domains [J].
Yang, Chao ;
Zhang, Shilei ;
Bai, Zhengya ;
Hou, Shasha ;
Wu, Di ;
Huang, Jian ;
Zhou, Peng .
MOLECULAR BIOSYSTEMS, 2016, 12 (04) :1201-1213
[86]   PHARMACODYNAMICS Which trails are your drugs taking? [J].
Zhang, Rumin .
NATURE CHEMICAL BIOLOGY, 2015, 11 (06) :382-383
[87]   A Systems Pharmacology Model for Predicting Effects of Factor Xa Inhibitors in Healthy Subjects: Assessment of Pharmacokinetics and Binding Kinetics [J].
Zhou, X. ;
Huntjens, D. R. H. ;
Gilissen, R. A. H. J. .
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2015, 4 (11) :650-659
[88]   Biophysical Mapping of the Adenosine A2A Receptor [J].
Zhukov, Andrei ;
Andrews, Stephen P. ;
Errey, James C. ;
Robertson, Nathan ;
Tehan, Benjamin ;
Mason, Jonathan S. ;
Marshall, Fiona H. ;
Weir, Malcolm ;
Congreve, Miles .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (13) :4312-4323